Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Neuroblastoma 3Melanoma 3Lung Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Neoplasms 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Gliosarcoma 2Glioma 2Glioblastoma 2Carcinoma, Renal Cell 2Brain Neoplasms 2Astrocytoma 2Advanced Malignant Solid Tumor 2Adenoma, Islet Cell 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdoid Tumor 1Resectable Pancreatic Cancer 1

Interventions

Temozolomide 10Radiotherapy 10Bevacizumab 6Everolimus 5ribociclib 3Radiation 3Panobinostat 3Dasatinib 3Valproic Acid 2TIC10 compound 2Re-Irradiation 2Nivolumab 2Mebendazole 2Irinotecan 2Gemcitabine 2GDC-0084 2Etoposide 2Erlotinib Hydrochloride 2Diphtheria-Tetanus Vaccine 2Cyclophosphamide 2Cilengitide 2Cetuximab 2vandetanib 1tovorafenib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diffuse Intrinsic Pontine Glioma × Colony-Stimulating Factors × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡